Invesco’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$470K Buy
203,671
+43,772
+27% +$101K ﹤0.01% 3181
2025
Q1
$222K Buy
159,899
+72,544
+83% +$101K ﹤0.01% 3463
2024
Q4
$151K Buy
87,355
+1,674
+2% +$2.9K ﹤0.01% 3548
2024
Q3
$172K Sell
85,681
-312,069
-78% -$627K ﹤0.01% 3530
2024
Q2
$891K Buy
+397,750
New +$891K ﹤0.01% 2983